^
BIOMARKER:

KLF4 overexpression

i
Other names: KLF4, EZF, GKLF, Kruppel-like factor 4 (gut)
Entrez ID:
Related biomarkers:
2ms
LINC00852 may be a prognostic biomarker for NSCLC. The epigenetic signaling pathway of LINC00852/hsa-miR-145-5p/KLF4 may be considered as a novel molecular target to fight NSCLC.
Clinical • Journal
|
KLF4 (Kruppel-like factor 4)
|
KLF4 overexpression
|
cisplatin
3ms
The level of KLF4 is correlated with the sensitivity of MCF-7 and T47D cells to PTX. DIM could enhance the antitumor efficacy of PTX on MCF-7 and T47D cells by regulating DNMT1 and KLF4.
Journal
|
KLF4 (Kruppel-like factor 4) • DNMT1 (DNA methyltransferase 1)
|
KLF4 overexpression • DNMT1 overexpression
|
paclitaxel